Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
We report a comparative analysis of the connections among 5-HT2CR editing, genome-wide gene expression and DNA methylation in suicide victims, individuals with major depressive disorder and non-psychiatric controls.
|
24781207 |
2014 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
The serotonin receptor 2C (HTR2C) gene has been shown to play a pivotal role in major depression.
|
23765961 |
2013 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
mRNA editing was assessed in prefrontal cortex of 24 MDD(Suic), 21 MDD(NoSuic), and 56 NC using next generation sequencing. mRNA expression of 5-HT(2C)R and editing enzymes (ADAR1-2) was assessed by real-time PCR.
|
22404657 |
2013 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
mRNA editing was assessed in prefrontal cortex of 24 MDD(Suic), 21 MDD(NoSuic), and 56 NC using next generation sequencing. mRNA expression of 5-HT(2C)R and editing enzymes (ADAR1-2) was assessed by real-time PCR.
|
22404657 |
2013 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
The serotonin receptor 2C (HTR2C) gene has been shown to play a pivotal role in major depression.
|
23765961 |
2013 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
Serotonin receptor 2C (HTR2C) has been postulated as being involved in the etiology or pathophysiology of mental disorders such as bipolar disorder, major depression and schizophrenia.
|
20015120 |
2010 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Serotonin receptor 2C (HTR2C) has been postulated as being involved in the etiology or pathophysiology of mental disorders such as bipolar disorder, major depression and schizophrenia.
|
20015120 |
2010 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Of the six HTR2C SNPs, only the T allele of the -759C/T SNP showed borderline significant associations with higher body mass index (BMI) (0.23 kg m(-2); (95% confidence interval (CI): 0.01-0.44); P=0.051) and increased risk of lifetime major depressive disorder (MDD) (Odds ratio (OR): 1.13 (95% CI: 1.01-1.22), P=0.02).
|
20065966 |
2010 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Of the six HTR2C SNPs, only the T allele of the -759C/T SNP showed borderline significant associations with higher body mass index (BMI) (0.23 kg m(-2); (95% confidence interval (CI): 0.01-0.44); P=0.051) and increased risk of lifetime major depressive disorder (MDD) (Odds ratio (OR): 1.13 (95% CI: 1.01-1.22), P=0.02).
|
20065966 |
2010 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
Here we overviewed the genetic, expression and RNA editing studies suggesting the close relationship between HTR2C and major mental disorders including schizophrenia, bipolar disorder and major depression.
|
19411841 |
2009 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
The new antidepressant agomelatine is the first melatonergic antidepressant with an innovative mode of action: it is a melatonergic MT(1), MT(2) receptor agonist and 5-HT(2c) antagonist, and is able to restore the internal clock, which is profoundly disturbed in depression, thus being efficacious in major depressive disorders.
|
19708722 |
2009 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
SNPs in CCKAR, DRD1, DRD2, and HTR2C genes showed nominally significant associations with MDD.
|
15927089 |
2006 |
Major Depressive Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In addition, homozygous or hemizygous carriers of the 5-HT2C Ser allele were 12 times more likely to have major depressive illness than homozygous or hemizygous carriers of the 5-HT2C Cys allele.
|
12707936 |
2003 |
Major Depressive Disorder
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Studies on mice revealed that 5-HT2C pre-mRNA editing is regulated in a serotonin-dependent manner, and postmortem studies on brain tissues of patients with schizophrenia and major depression found distinct site-specific alterations of this editing in the prefrontal cortex, a brain region expressing a large number of differently edited 5-HT2C mRNA isoforms.
|
12934707 |
2003 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
These findings are in accordance with the previous findings, and suggest that altered RNA editing of HTR2C may have some significance in major depression and suicide.
|
12853111 |
2003 |
Major Depressive Disorder
|
0.400 |
Biomarker
|
disease |
BEFREE |
An examination of the efficiencies of RNA editing of the 5-HT(2C)R in prefrontal cortex of control individuals vs. subjects diagnosed with schizophrenia or major depressive disorder revealed no significant differences in RNA editing among the three populations.
|
11282248 |
2001 |